Literature DB >> 6834080

Prediction of response to plasma exchange in chronic relapsing polyneuropathy. A clinico-pathological correlation.

J D Pollard, J G McLeod, P Gatenby, H Kronenberg.   

Abstract

The clinical features, results of nerve conduction studies and sural nerve biopsy findings have been compared in 5 patients with chronic relapsing polyneuropathy in whom plasma exchange was used in treatment. In 2 patients who consistently responded to plasma exchange, the dominant pathological findings was segmental demyelination without prominent onion bulb formation, whereas axonal degeneration was more prominent in the cases which did not respond. It is concluded that in cases of chronic relapsing polyneuritis where the clinical, electrophysiological and histological features suggest primary demyelination, plasma exchange may provide a useful adjunct to therapy.

Entities:  

Mesh:

Year:  1983        PMID: 6834080     DOI: 10.1016/0022-510x(83)90222-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  Chronic Inflammatory Demyelinating Polyneuropathy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.598

Review 2.  Plasmapheresis for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Man Mohan Mehndiratta; Avinash Chandra Singh
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.806

3.  An update on the management of chronic inflammatory demyelinating polyneuropathy.

Authors:  Kenneth C Gorson
Journal:  Ther Adv Neurol Disord       Date:  2012-11       Impact factor: 6.570

4.  IgG immunoadsorption in experimental allergic neuritis: effect on antibody levels and clinical course.

Authors:  G K Harvey; K Schindhelm; J D Pollard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

5.  Rare association of herpes simplex virus IgM-specific antibodies and Guillain-Barré syndrome successfully treated with plasma exchange and immunosuppression.

Authors:  G Gerken; F Trautmann; H Köhler; D Falke; J Bohl; W Nix; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1985-05-15

6.  Treatment of peripheral neuropathies.

Authors:  M Hallett; D Tandon; A Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

7.  Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy.

Authors:  S J Hodgkinson; J D Pollard; J G McLeod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-04       Impact factor: 10.154

8.  IgG monoclonal paraproteinaemia and peripheral neuropathy.

Authors:  A F Bleasel; S H Hawke; J D Pollard; J G McLeod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

9.  Chronic relapsing idiopathic polyneuropathy with primary axonal lesions.

Authors:  J Julien; C Vital; A Lagueny; X Ferrer; C Brechenmacher
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

10.  Relapsing inflammatory demyelinating polyneuropathy in a diabetic patient.

Authors:  C Vital; P Dumas; D Latinville; M Dib; A Vital; C Brechenmacher
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.